Evidence map›Paper›PMID 39841063›Full record

ArticleRadiology. Artificial intelligence2025

Impact of Scanner Manufacturer, Endorectal Coil Use, and Clinical Variables on Deep Learning-assisted Prostate Cancer Classification Using Multiparametric MRI.

José Guilherme de Almeida, Nuno M Rodrigues, Ana Sofia Castro Verde, Ana Mascarenhas Gaivão, Carlos Bilreiro, Inês Santiago, Joana Ip, Sara Belião, Celso Matos, Sara Silva and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Radiology. Artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Artificial Intelligence Is Brittle: We Need to Do Better.Radiology. Artificial intelligence · 2025
    Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

José Guilherme de AlmeidaChampalimaud Research, Champalimaud Foundation, Avenida Brasilia, Lisboa, Lisboa 1400-038 Portugal.ORCID 0000-0002-1887-0157
Nuno M RodriguesChampalimaud Research, Champalimaud Foundation, Avenida Brasilia, Lisboa, Lisboa 1400-038 Portugal.
Ana Sofia Castro VerdeChampalimaud Research, Champalimaud Foundation, Avenida Brasilia, Lisboa, Lisboa 1400-038 Portugal.ORCID 0000-0001-6729-5681
Ana Mascarenhas GaivãoDepartment of Radiology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
Carlos BilreiroDepartment of Radiology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.ORCID 0000-0001-7755-0842
Inês SantiagoDepartment of Radiology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
Joana IpDepartment of Radiology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.ORCID 0000-0002-5297-4515
Sara BeliãoDepartment of Radiology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
Celso MatosChampalimaud Research, Champalimaud Foundation, Avenida Brasilia, Lisboa, Lisboa 1400-038 Portugal.ORCID 0000-0001-7383-6309
Sara SilvaLASIGE, Faculdade de Ciências, Universidade de Lisboa, Portugal.
Manolis TsiknakisDepartment of Electrical and Computer Engineering, Hellenic Mediterranean University, Heraklion, Greece.
Kostantinos MariasDepartment of Electrical and Computer Engineering, Hellenic Mediterranean University, Heraklion, Greece.ORCID 0000-0003-3783-5223
Daniele ReggeDepartment of Radiology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
Nikolaos PapanikolaouChampalimaud Research, Champalimaud Foundation, Avenida Brasilia, Lisboa, Lisboa 1400-038 Portugal.ORCID 0000-0003-3298-2072
ProCAncer-I ConsortiumPartners of the ProCAncer-I Consortium are listed at https://www.procancer-i.eu/.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose To assess the effect of scanner manufacturer and scanning protocol on the performance of deep learning models to classify aggressiveness of prostate cancer (PCa) at biparametric MRI (bpMRI). Materials and Methods In this retrospective study, 5478 cases from ProstateNet, a PCa bpMRI dataset with examinations from 13 centers, were used to develop five deep learning (DL) models to predict PCa aggressiveness with minimal lesion information and test how using data from different subgroups-scanner manufacturers and endorectal coil (ERC) use (Siemens, Philips, GE with and without ERC, and the full dataset)-affects model performance. Performance was assessed using the area under the receiver operating characteristic curve (AUC). The effect of clinical features (age, prostate-specific antigen level, Prostate Imaging Reporting and Data System score) on model performance was also evaluated. Results DL models were trained on 4328 bpMRI cases, and the best model achieved an AUC of 0.73 when trained and tested using data from all manufacturers. Held-out test set performance was higher when models trained with data from a manufacturer were tested on the same manufacturer (within- and between-manufacturer AUC differences of 0.05 on average,

Indexed as

Deep LearningImage Interpretation, Computer-AssistedMultiparametric Magnetic Resonance ImagingProstatic NeoplasmsAgedHumansMaleMiddle AgedRetrospective StudiesComputer-aided Diagnosis (CAD)Computer Applications–General (Informatics)Convolutional Neural Network (CNN)Oncology

Identifiers

PMID39841063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.